ICAP Ocean Tomo
CHICAGO, March 17, 2011 /PRNewswire/ -- Developed by Aqueous Pharma Limited and represented by ICAP Ocean Tomo, this patent pending technology discloses an improved formulation for treating eye disease, specifically chronic dry eye. The assets in this portfolio will be auctioned at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City.
(Logo: https://photos.prnewswire.com/prnh/20100614/CG20517LOGO)
Key Characteristics & Benefits
Market Potential
This lot should be of interest to pharmaceutical companies, drug manufacturers, and others in the healthcare field.
To learn more about the assets available for sale in this portfolio:
Contact Dean Becker of ICAP Ocean Tomo at [email protected]
About ICAP Ocean Tomo LLC
ICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world's premier patent auction firm.
About ICAP
ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.
(1) http://www.prweb.com/releases/cbdmt/dryeyedisease/prweb3924374.html
CONTACT: Cali Munoz of ICAP Ocean Tomo, +1-312-618-8385,
[email protected]
Web site: http://www.icapoceantomo.com/